CHRISTINA CONNELLY: Open Payments
NPI 1750739702 · PORTAGE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 34 payments from 13 companies in 2025. Trend: 2023 $574 · 2024 $371 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 5 | $156 |
| Otsuka America Pharmaceutical, Inc. | 5 | $83 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $66 |
| Orexo US, Inc. | 3 | $65 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Lundbeck LLC | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Verona Pharma, Inc. | 2 | $40 |
| ABBVIE INC. | 2 | $34 |
Products named: FANAPT, REXULTI, TRELEGY ELLIPTA, CAPLYTA, Zubsolv, Auvelity, Ohtuvayre, FARXIGA.
Industry payments across IN — which companies pay providers there.
